In vivo metabolism of2-[1'-phenyl-3'-(3chlorophenyl)-2'-propenylyden]hydrazino-3-methyl4(3H)-quinazolinone in rats
No Thumbnail Available
Date
2005
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The aim of this study was to investigate by HPLC the in vivo metabolism of 2-[1'-phenyl-3'-(3-chlorophenyl)-2'propenylyden]hydrazino-3-methyl-4(3H)-quinazolinone as a substrate, and as a model compound in rats. The substrate was dissolvedin DMSO/water (1:4) and administered intraperitoneally at a dose of 100mg/kgin a volume of approximately 0.1 mL. Blood samples were taken before and 30 min, 1.5,3,6,9, 11,30and 48 h after i.p, drug administration. The chromatographic separation of the substrate and its metabolites was performed usinga stainless steel Novopak CI8 column (150 x 4.6 mm i.d.,5urnparticle size).The optimal composition of the mobile phase wasreached by introducing different mixtures of pure acetonitrile and water in a linear gradient system. Following the biotransformation of this compound, 2-hydrazino-3-methyl-4(3H)quinazolinone (MI) and 3-(3-chlorophenyl)-I-phenylprop-2-en-l-one (M2) derivatives were identified together withsubstrate by comparing them to reference standards usingHPLC-UV/DAD.In addition, the composition of these metabolites andsubstrate was confirmed by LC-MS in plasma
Description
Keywords
2-[1-phenyl-3-(chloropheny1)-2-propenylyden]hydrazino-3-methyl-4(3H)-quinazolinone, HPLC, İn vivo metabolism.